DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,565 filers reported holding DANAHER CORPORATION in Q2 2020. The put-call ratio across all filers is 1.06 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,759,864 | +3.1% | 11,124 | -0.3% | 2.14% | +10.7% |
Q2 2023 | $2,676,960 | -4.9% | 11,154 | -0.2% | 1.93% | -8.7% |
Q1 2023 | $2,816,295 | -5.3% | 11,174 | -0.3% | 2.11% | -13.2% |
Q4 2022 | $2,973,766 | +0.3% | 11,204 | -2.4% | 2.43% | -8.1% |
Q3 2022 | $2,966,000 | -0.4% | 11,484 | -2.2% | 2.65% | +7.1% |
Q2 2022 | $2,977,000 | -14.8% | 11,744 | -1.4% | 2.47% | +1.1% |
Q1 2022 | $3,493,000 | -11.2% | 11,909 | -0.3% | 2.44% | -6.3% |
Q4 2021 | $3,932,000 | +6.6% | 11,950 | -1.4% | 2.61% | -2.7% |
Q3 2021 | $3,690,000 | +12.0% | 12,120 | -1.3% | 2.68% | +12.9% |
Q2 2021 | $3,295,000 | +14.6% | 12,277 | -3.8% | 2.38% | +6.4% |
Q1 2021 | $2,874,000 | -0.2% | 12,767 | -1.5% | 2.23% | -3.7% |
Q4 2020 | $2,880,000 | +1.6% | 12,967 | -1.5% | 2.32% | -9.9% |
Q3 2020 | $2,834,000 | +20.3% | 13,162 | -1.2% | 2.57% | +10.2% |
Q2 2020 | $2,356,000 | +27.1% | 13,322 | -0.5% | 2.33% | +3.0% |
Q1 2020 | $1,853,000 | -12.8% | 13,387 | -3.3% | 2.26% | +16.3% |
Q4 2019 | $2,124,000 | +7.3% | 13,837 | +0.9% | 1.95% | -0.7% |
Q3 2019 | $1,980,000 | -1.9% | 13,707 | -3.0% | 1.96% | -3.3% |
Q2 2019 | $2,019,000 | +7.3% | 14,127 | -0.9% | 2.03% | +3.3% |
Q1 2019 | $1,882,000 | +28.6% | 14,252 | +0.4% | 1.96% | +8.6% |
Q4 2018 | $1,463,000 | – | 14,192 | – | 1.81% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |